Pharmafile Logo
Pharmafocus logo
Advanced Search

Uniphar appoints new global head of Scientific Communications

January 17, 2025
UniPhar, appointment

Global partner to pharma, medtech and biotech companies Uniphar has announced the appointment of industry leader Isaac Batley as its …

Appointment

Pharmapack Predictions 2025: the Good the Bad and…. the Donald 2.0

January 17, 2025
CPhI, Pharmpack, biologics, predictions

Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025 13 …

News
Press release

David Loose appointed CEO of Essex Management

January 17, 2025

David Loose has been appointed as chief executive officer of Essex Management, part of contract research organisation Emmes Group. After …

Appointment

Dr Joerg Moeller appointed CEO of Antag Therapeutics

January 14, 2025
Corporate

Novel obesity treatment-focused biopharmaceutical company Antag Therapeutics has announced the appointment of Joerg Moeller MD PhD as chief executive officer. …

Appointment

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

January 14, 2025
Switzerland, pharmapack, report

 Pharmapack Europe: ‘Basel the best location for drug device innovation in Europe thanks to combination of world class manufacturing and …

News
Press release

University of Sheffield trial highlights immunotherapy-related improved survival rates for bladder cancer patients

January 14, 2025
Research and Development Endocrinology, Oncology, Sheffield, astranzeneca, bladder cancer, immunotherapy, patients

The University of Sheffield, UK, have announced study results for its trial into the survival rates of patients with operable …

News

AnaCardio raises $19m in funding round for heart failure candidate

January 10, 2025
Research and Development AnaCardio, Cardiology, cardiology, funding, heart failure

Swedish biopharmaceutical company AnaCardio has announced the completion of a Series A extension financing round that has raised $19m for …

News
handshake_2

IDDI announces two new appointments to its leadership team

January 9, 2025
IDDI, appointment, leadership

The International Drug Development Institute (IDDI) has announced changes to its executive leadership team to strengthen the company’s leadership and …

Appointment

University of Southern Denmark pairs with Argobio to launch next-generation RNA company Inverna Therapeutics

January 7, 2025
Research and Development Argobio, Huntingdon's Disease, Inverna therapeutics, Neurology, RNA therapeutics, University of Southern Denmark ], gene splicing

The launch of new RNA company Inverna Therapeutics was announced today. Inerva Therapeutics begins with a programme aimed at transforming …

News

NMD Pharma’s Charcot-Marie-Tooth disease treatment granted ODD by FDA

January 6, 2025
CMT, FDA, NMD Pharma, Orphan Drugs, Pain, nervous system, research and development

Biotech company NMD Pharma has announced that the US Food and Drug Association (FDA) have granted its Charcot-Marie-Tooth (CMT) disease …

News

NDA in China receives priority review status for lung cancer treatment

January 3, 2025
Research and Development China, China National Medical products Administration, HUTCHMED, NDA, Oncology, epidermal growth factor receptor, non-small cell lung cancer, priority review

HUTCHMED have announced that the China National Medical Products Administration (NMPA) have granted a priority review for a new drug …

News

NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer

December 19, 2024
ESR1, Menari Group, NICE, breast cancer, drug

Elacestrant is the first tailored treatment for certain people with oestrogen receptor (ER)-positive HER2-negative locally advanced and metastatic breast cancer …

News
Press release

MHRA Grants Marketing Authorisation for LEO Pharma’s Anzupgo® ▼(delgocitinib) cream in Great Britain

December 16, 2024
LEO Pharma, eczema

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation in Great Britain for Anzupgo® (delgocitinib) 20mg/g cream …

News
Press release

Pharma prepares for CDMO growth in 2025 as CPHI Milan reports record attendance

December 13, 2024
CPHI Milan, CPhI, networking

13 December 2024 – Amsterdam, the Netherlands –  CPHI Milan – the world’s largest pharma event – hosted last month …

News
Press release

Deep Science Ventures and General Inception collaborate to create fibrosis-focused therapeutics company

December 12, 2024
Corporate, Deep Science Ventures, General Inception, fibrosis, venture

12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and …

News
Press release

NICE RECOMMENDS LILLY’S TIRZEPATIDE (MOUNJARO ®▼) FOR MANAGING OVERWEIGHT AND OBESITY IN FINAL DRAFT GUIDANCE

December 10, 2024
Mounjaro, NICE, lilly, weight-loss

BASINGSTOKE, 5th December 2024 – Eli Lilly and Company announced today that the National Institute for Health and Care Excellence …

News
Press release

UCB presents epilepsy research at American Epilepsy Society Annual Meeting

December 9, 2024
Research and Development American Epilepsy Society, Dravet Syndrome, Neurology, UCB, sleep

Belgian-based biopharmaceutical company UCB has announced it will present 32 abstracts at the American Epilepsy Society (AES) Annual Meeting – …

News

Gemma Cathcart appointed managing partner at Langland

November 25, 2024
Corporate, Langland

Langland, a medical life sciences company with focuses on areas surrounding Clinical Trial experience, Medical Strategy and Education, Public Relations …

Appointment

Ceryx Medical Initiates First-In-Human Study of the Cysoniâ„¢ RSA Pacemaker

November 21, 2024
Ceryx Medical, Devices, biotech

Ceryx’s Cysoni pacing technology is designed to provide superior therapeutic outcomes for Heart Failure patients by improving cardiac output using …

News
Press release

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

November 20, 2024
AMR Week, Glox Therapeutics, antimicrobial resistance

Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025